GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-0.18 Cr | ₹-0.23 Cr | ₹-0.14 Cr | ₹0.00 Cr | ₹0.15 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of GENNEX LABORATORIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-0.18 Cr |
| Mar2024 | ₹-0.23 Cr |
| Mar2023 | ₹-0.14 Cr |
| Mar2022 | ₹0.00 Cr |
| Mar2021 | ₹0.15 Cr |
How is Deferred Tax Assets / Liabilities of GENNEX LABORATORIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.18 Cr | Negative | |
| Mar2024 | ₹-0.23 Cr | Negative | |
| Mar2023 | ₹-0.14 Cr | Negative | |
| Mar2022 | ₹0.00 Cr | -98.04 | |
| Mar2021 | ₹0.15 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹240.7 Cr | -1.7% | -16% | -13.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,120.0 Cr | -3.2% | -5.4% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,390.0 Cr | 0.7% | 3.2% | 61.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,740.0 Cr | -2.8% | -3% | 32.6% | Stock Analytics | |
| CIPLA | ₹108,497.0 Cr | -2.9% | -3.3% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,925.0 Cr | -3.3% | 4.7% | -2.2% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -1.7% |
-16% |
-13.4% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses